No active 13F manager changed its position in enVVeno Medical Corp last quarter. Over the last 180 days, 1 insider sold and none bought, a net -$3K in open-market trades.
No active-manager 13F changes; insiders net sold $3K.
Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Duhay Francis | Director | Sell (S) | 140 | $1K |
| Mar 12, 2026 | Duhay Francis | Director | Sell (S) | 140 | $2K |
| Dec 11, 2025 | Duhay Francis | Director | Sell (S) | 5K | $2K |
| Sep 15, 2025 | Duhay Francis | Director | Sell (S) | 5K | $4K |
| Dec 31, 2024 | Gray Robert | Director | Buy (P) | 4K | $10K |
| Dec 31, 2024 | Duhay Francis | Director | Buy (P) | 81K | $250K |
| Dec 24, 2024 | Shrivastava Sanjay | Director | Buy (P) | 5K | $16K |
| Dec 19, 2024 | Jenusaitis Matthew | Director | Buy (P) | 10K | $24K |
| Dec 19, 2024 | BERMAN ROBERT ANDREW | Chief Executive Officer, Director | Buy (P) | 12K | $31K |
| Mar 13, 2024 | Alavi Hamed | Chief Technology Officer | Sell (S) | 8K | $52K |
| Aug 16, 2022 | Duhay Francis | Director | Buy (P) | 8K | $48K |
| Jun 30, 2022 | Shrivastava Sanjay | Director | Buy (P) | 1K | $4K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Latest quarterly filings | 0 | 0 | – |
Insiders Form 4 open-market | 0 | 1 | -$3K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital DISCLOSED rotating, as of the latest public SEC 13F filings. It is DATA, NOT investment advice, a recommendation, or a prediction. Filings lag ~45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for enVVeno Medical Corp
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/HIJI/capital-change-brief"
Use Arkolith's capital_change_brief for enVVeno Medical Corp. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for HIJI. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.